An efficient gene targeting system using Δku80 and functional analysis of Cyp51A in Trichophyton rubrum

Masaki Ishii1, Tsuyoshi Yamada2,3, Shinya Ohata4

  • 1Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo, 202-8585, Japan. m_ishii@musashino-u.ac.jp.

AMB Express
|August 31, 2024
PubMed

Insights

Researchers developed a new gene targeting system for Trichophyton rubrum, a common cause of fungal infections. This system enhances the study of drug resistance, particularly azole antifungal drug tolerance, by targeting the Cyp51A gene.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Trichophyton rubrum is a prevalent cause of dermatophytosis.
  • Understanding T. rubrum's drug resistance and pathogenicity is hindered by a lack of efficient genetic tools.

Purpose of the Study:

  • To develop an efficient gene targeting system for T. rubrum.
  • To investigate the role of Cyp51A in azole antifungal drug resistance.

Main Methods:

  • Generated a ku80-deficient (Δku80) T. rubrum strain for enhanced genetic recombination.
  • Developed a gene targeting system with significantly improved efficiency.
  • Created a mutant by inserting the nptII gene into the cyp51A 3'-untranslated region to destabilize cyp51A mRNA.
  • Assessed the impact of this mutation on efinaconazole-induced cyp51A expression and azole drug susceptibility.

Main Results:

  • The Δku80 strain exhibited a 46-fold increase in gene targeting efficiency compared to the wild-type.
  • Expression of cyp51A mRNA was induced by efinaconazole, unlike cyp51B.
  • The cyp51A mutant showed diminished cyp51A mRNA induction and reduced minimum inhibitory concentrations for azole drugs.
  • These findings indicate Cyp51A contributes to azole drug tolerance in T. rubrum.

Conclusions:

  • An efficient gene targeting system using Δku80 in T. rubrum is established.
  • This system is valuable for analyzing genes involved in drug resistance, such as Cyp51A.
  • Cyp51A plays a significant role in dermatophyte tolerance to azole antifungal drugs.